Protara Therapeutics, Inc.(TARA)

Sector:

Healthcare

Description:

Protara Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the identifying and advancing transformative therapies for the treatment of cancer and rare diseases. The company's lead program is TARA-002, an investigational cell therapy for the treatment of lymphatic malformations. It also develops intravenous choline chloride, an investigational phospholipid substrate replacement therapy for the treatment of intestinal failure associated liver disease. The company was formerly known as ArTara Therapeutics, Inc. and changed its name to Protara Therapeutics, Inc. in May 2020. Protara Therapeutics, Inc. is headquartered in New York, New York.

Current Price

$2.90

RSI

43.41

Market Capitalization:

70.7M

Beta:

None

Volume:

19,235

Analyst Target Price:

$ 37.33

Economiic Fair Price:


November 02, 2022
November 03, 2022
Q3
N/A
N/A
N/A
N/A
47.5M
6.6M
-4.083
N/A
0
-0.251

$ -35.1M
-44.49 %
$ -24.3M
-55.10 %
$ -15.7M
32.93 %
$ -23.4M
-4.31 %
$ -22.4M
6.56 %
$ -24M

News

Press Releases

Notable Dates